Press release -
In Vitro Diagnostics Global Market to grow by 4.9% (2008-2018) to reach $72.7 billion by 2018
The In Vitro Diagnostic (IVD) industry has been confronting a range of issues, such as regulations, industry consolidation, reforms in healthcare, low level of technological innovations and ever-changing demographics. Though some of these challenges may seem insurmountable, the glimmer of hope always exists that could rejuvenate the IVD industry over the coming years. Improvement in healthcare infrastructure, growth in personalized medicine based on bespoke solutions and companies’ focus towards growth-centric emerging markets certainly constitute some of the major factors that can be looked up to.
The arrival of novel technologies and innovations has spawned assays and biomarkers that would play crucial roles in the high-growth areas of infectious diseases, women’s health, cancer and cardiovascular conditions. Molecular diagnostics and the genomic reform have been the primary drivers of this growth, which are expected to sustain this level not only by tailoring existing drug therapies for individual patients, but also through developing new drug therapies that would enable in the better identification of patient populations that could prospectively benefit from drug treatment. Companies would do well to concentrate on tests based on biomarkers, such as those utilizing protein-based biomarkers for Alzheimer’s disease, and the genomic revolution, with solutions using gene-based testing for indicating the probability of a range of cancers.
Though it may seem that the IVD industry is at a vital crossroad, looking hither and thither, the key point remains focusing on the above-mentioned areas to garner adequate standing that would enable in a complete turnaround. Personalized medicine appears to be a crucial aspect that has to be looked into with detail, so as to ascertain where the future of this industry lies.
The report reviews, analyses and projects IVD market for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 22 independent countries across North America – United States, Canada and Mexico; Europe – Western Europe (Germany, France, Italy, Spain, United Kingdom, Belgium, Netherlands, Switzerland, Portugal, Austria, Greece, Scandinavia and Rest of Western Europe) and Eastern Europe (Poland, Czech Republic, Russia and Rest of Eastern); Asia-Pacific –Japan, China, India and Rest of Asia-Pacific; South America – Argentina, Brazil and Rest of South America; and Rest of World.
Market for IVD product categories analyzed in this study includes Reagents & Consumables and Instruments & Systems. The report also includes the market analysis for end-use application analysis of IVDs – Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics, Pathology, Cellular Analysis and Microbiology.
This 493 page global market report includes 284 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, product category and application area. The report comprises the brief business profiles of 47 key global players and 60 major players across the United States – 36; Europe – 18; and Asia-Pacific – 6. The report also provides the listing of the companies engaged in research and development, equipment manufacturing, processing, supplies and distribution of In Vitro Diagnostics. The global list covers the addresses, contact numbers and the website addresses of 382 companies.
For more details, please visit http://industry-experts.com/verticals/healthcare/in-vitro-diagnostics-a-global-market-overview.html
Topics
- Health, Health Care, Pharmaceuticals
Categories
- clinical chemistry
- immunoassay
- diabetes testing
- blood testing
- molecular diagnostics
- pathology
- cellular analysis
- microbiology
Industry Experts caters the market research needs of a broad range of industry verticals comprising Automobile, Healthcare, Food & Beverage, Chemicals & Plastics, Consumer Goods, Biotechnology and Other. The company also provides customized market research and industry analysis services for a wide range of industry sectors.